Background Medical cannabis policies often raise concerns about substitution of prescription medications with cannabis, yet most evidence is quantitative. Drawing on the concept of lay pharmacology, this qualitative study examined how medical cannabis patients manage prescription medications alongside cannabis use.Methods Data were drawn from an ongoing cohort of Pennsylvania-based medical cannabis patients. Thirty-seven participants (mean age = 38, 62% female) with a history of prescription medication use completed qualitative interviews in 2022-2023. Iterative thematic analysis identified medication management strategies.Results Participants described complex medication histories and concerns about prescription medications, including pill burden, side effects, limited efficacy, and addiction risk. However, they differed in how they managed prescription medications in the context of cannabis use. Three strategies were identified: (1) Medication Cessation (n = 8), involving discontinuation of all prescription medications in favor of cannabis; (2) Medication Reconfiguration (n = 14), characterized by dose reduction, selective discontinuation, or alternating medications with cannabis; and 3) Medication Prioritization (n = 15), in which participants maintained prescription regimens while adjusting cannabis use.Conclusion Complete substitution was uncommon. Instead, patients engaged in adaptive, experience-based medication management consistent with lay pharmacology. Findings highlight the need for policy frameworks and clinical guidelines that support individualized, patient-centered, and collaborative approaches to care.
Journal article
Beyond substitution: how medical cannabis patients manage prescription medications
Drugs : education, prevention & policy, pp 1-13
08 Sep 2026
Featured in Collection : Drexel's Newest Publications
Abstract
Metrics
1 Record Views
Details
- Title
- Beyond substitution: how medical cannabis patients manage prescription medications
- Creators
- Janna Ataiants (Corresponding Author) - Drexel UniversityMaddy Finkelstein - Drexel UniversityBenjamin Cocchiaro - Drexel UniversityEkaterina Fedorova - Drexel UniversityClive Stevens - Drexel UniversityStephen E. Lankenau - Drexel University
- Publication Details
- Drugs : education, prevention & policy, pp 1-13
- Publisher
- Taylor & Francis
- Number of pages
- 13
- Grant note
- Verano
This work was supported by a multi-year research agreement between Drexel University and Verano (a multi-state cannabis company). The funder had no role in the study design, data collection, analysis, interpretation, writing of the manuscript, or the decision to submit the manuscript for publication.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- MD (Doctor of Medicine) Program; Urban Health Collaborative; Dana and David Dornsife School of Public Health; Community Health and Prevention
- Web of Science ID
- WOS:001870092400001
- Other Identifier
- 991022207141104721